Alzheimer : the next focus of biotechnologies.

14 Jul

Altogether! : industrials, academics, patients associations, and regulator agree to enlarge the inclusion criteria in clinical trials aiming to test new drugs indicated in Alzheimer disease.

The goal is to evaluate bio engineering issued medicine called “bapineuzumab” in 2012 and 2013.

Bio engineering drugs are among the most expansive drugs because they are issued from genetically modified cells.  All their names end with the acronym “umab” which means Human Anti Body.

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: